UONDDL
RYTM icon

University of Notre Dame du Lac’s Rhythm Pharmaceuticals RYTM Stock Holding History

University of Notre Dame du Lac’s Portfolio RYTM Stock Details RYTM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q1 		– Sell
-44,390
Closed -$1.02M – 61
2019
Q4 		$1.02M Sell
44,390
-391
-0.9% -$8.69K 0.32% 42
2019
Q3 		$967K Sell
44,781
-93,916
-68% -$2.01M 0.29% 41
2019
Q2 		$3.05M Buy
+138,697
New +$3.5M 0.69% 54

Other funds holding RYTM

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
NMC
NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return

University of Notre Dame du Lac's RYTM Position: Q1 2020 in Review

University of Notre Dame du Lac sold out of Rhythm Pharmaceuticals (RYTM) in Q1 2020, closing a stake of 44,390 shares — an estimated $1.02M sold.

University of Notre Dame du Lac first reported a position in RYTM in Q2 2019 and held it in 3 quarters. The position peaked at $3.05M in Q2 2019. 80 funds tracked by Wall St. Rank hold RYTM as of Q1 2020.

  • University of Notre Dame du Lac reported no remaining Rhythm Pharmaceuticals position as of Q1 2020 after selling out during the quarter.
  • University of Notre Dame du Lac sold 44,390 Rhythm Pharmaceuticals shares in Q1 2020, an estimated $1.02M.
  • University of Notre Dame du Lac first reported a position in Rhythm Pharmaceuticals in Q2 2019 and held it in 3 quarters.
  • University of Notre Dame du Lac's Rhythm Pharmaceuticals position peaked at $3.05M in Q2 2019.
  • 80 funds tracked by Wall St. Rank held Rhythm Pharmaceuticals as of Q1 2020.

Based on University of Notre Dame du Lac's 13F filing for Q1 2020, filed 15 May 2020.